Bogomil Voykov

First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery

Norbert Pfeiffer, Bogomil Voykov, Giulia Renieri et al. · PLoS ONE · 2017 · 68 citations · Full text

Medicine, Ophthalmology, Surgery +15

CRITICAL EVALUATION OF THE USABILITY OF AUGMENTED REALITY OPHTHALMOSCOPY FOR THE TRAINING OF INEXPERIENCED EXAMINERS

Martin Leitritz, Focke Ziemssen, Daniela Suesskind et al. · Retina · 2013 · 61 citations

Medicine, Medical Education, Ophthalmology +14

Long-term outcome of scleral-fixated posterior chamber intraocular lens implantation with the knotless Z-suture technique

Spyridon Dimopoulos, Vasileios Dimopoulos, Gunnar Blumenstock et al. · Journal of Cataract & Refractive Surgery · 2018 · 56 citations

Medicine, Ophthalmology, Surgery +13

Systemic corticosteroids for subcutaneous panniculitis‐like T‐cell lymphoma

Emmanuella Guenova, Stefan Schanz, Wolfram Hoetzenecker et al. · British Journal of Dermatology · 2014 · 47 citations

Medicine, Oncology, Pharmacotherapy +16

Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years?

Bogomil Voykov, Faik Gelişken, W. Inhoffen et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2010 · 39 citations

Medicine, Ophthalmology, Vision Science +13